XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Unaudited Condensed Consolidated Statement of Cash Flows
£ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2021
USD ($)
Jun. 30, 2021
GBP (£)
Jun. 30, 2020
GBP (£)
Dec. 31, 2020
USD ($)
Dec. 31, 2020
GBP (£)
Dec. 31, 2019
GBP (£)
Dec. 31, 2018
GBP (£)
Cash Flows from Operating Activities:              
Net income (loss) | $ $ 58,486,892     $ (113,069,866)      
Formation cost paid by Sponsor in exchange for issuance of Class B ordinary shares | $       5,000      
Interest earned on marketable securities held in Trust Account | $ (156,850)     (97,827)      
Unrealized gain on marketable securities held in Trust Account | $ 12,552     (11,540)      
Transaction costs allocable to warrant liabilities | $       1,316,194      
Change in fair value of warrant liability | $ (64,296,618)     111,326,374      
Other cash flows from operating activities:              
Investment of cash in Trust Account | $       (804,990,900)      
Net cash used in investing activities | $       (804,990,900)      
Proceeds from Executive Loans | $ 3,500,000            
Changes in operating assets and liabilities:              
Prepaid expenses | $ 912,528     (3,331,178)      
Accrued expenses | $ 2,824,882     91,069      
Net cash used in operating activities | $ (2,216,614)     (3,771,774)      
Cash Flows from Investing Activities:              
Proceeds from sale of Units, net of underwriting discounts paid | $       788,891,082      
Proceeds from sale of Private Placement Warrants | $       21,129,818      
Proceeds from promissory note – related party | $       500,000      
Repayment of promissory note – related party | $       (500,000)      
Payment of offering costs | $       (624,871)      
Net cash (used in)/generated from financing activities | $ 3,500,000     809,396,029      
Net (decrease)/increase in cash and cash equivalents | $ 1,283,386     633,355      
Cash and cash equivalents at the beginning of the period | $ 633,355          
Cash and cash equivalents at the end of the period | $ 1,916,741     633,355      
Non-Cash Investing and Financing Activities:              
Initial classification of Class A ordinary shares subject to possible redemption | $       720,744,700      
Change in value of Class A ordinary shares subject to possible redemption | $ $ 185,045,198     (100,545,333)      
Offering costs paid directly by Sponsor from proceeds from issuance of Class B ordinary shares | $       20,000      
Deferred underwriting fee payable | $       28,174,682      
Forfeiture of Founder Shares | $       $ (64)      
AJAX I [Member]              
Cash Flows from Operating Activities:              
Net income (loss)   £ (102,113) £ (30,766)   £ (102,687) £ (17,964) £ (179)
Depreciation of property, plant, and equipment   10,531 2,039   11,759 705
Amortisation of intangible assets   4,618 457   1,292 76
Finance income   (166) (185)   (486) (170)
Finance expense   1,793 627   1,361 456
Share based payment expense   12,688 326   3,759 199
Tax credit   (7,326)   (969)
Adjustments to reconcile profit (loss)   (79,975) (27,502)   (85,965) (16,698) (179)
Movements in working capital:              
Decrease/(increase) in trade and other receivables   8,508 (10,571)   (4,789) (12,158) (49)
Increase in inventory   (12,294) (3,095)   (36,961) (42,970)
Increase in trade and other payables   28,106 9,727   10,394 4,123 114
Total working capital movements   24,320 (3,939)   (31,356) (51,005) 65
Other cash flows from operating activities:              
Interest received   166 185   478 149
Tax credit received         969
Purchases of property, plant, and equipment   (34,685) (568)   (17,919) (2,422)
Net cash used in investing activities   (119,190) (1,255)   (36,338) (5,666) (20)
Purchases and development of intangible fixed assets   (4,810) (687)   (1,889) (3,244) (20)
Acquisition of subsidiaries, net of cash acquired   (79,695)   (16,530)
Issue of ordinary shares         348,870 50,000 26,500
Proceeds from issue of shares   125,000        
Proceeds from stocking loans   217,399 49,152   216,444 42,825
Repayment of stocking loans   (218,520) (49,509)   (196,082) (10,348)
Repayment of mortgages   (1,070)   (443)
Interest paid on loans and borrowings   (1,711) (627)   (1,298) (456)
Lease payments   (4,596) (3,188)   (6,294) (628)
Changes in operating assets and liabilities:              
Net cash used in operating activities   (55,489) (31,256)   (115,874) (67,554) (114)
Cash Flows from Investing Activities:              
Net cash (used in)/generated from financing activities   (8,498) 120,828   361,197 81,393 26,500
Net (decrease)/increase in cash and cash equivalents   (183,177) 88,317   208,985 8,173 26,366
Cash and cash equivalents at the beginning of the period   243,524 34,539   34,539 26,366
Cash and cash equivalents at the end of the period   £ 60,347 £ 122,856   £ 243,524 £ 34,539 £ 26,366